CA2220103A1 - Compositions a base d'amoxycilline et d'acide clavulanique - Google Patents

Compositions a base d'amoxycilline et d'acide clavulanique

Info

Publication number
CA2220103A1
CA2220103A1 CA002220103A CA2220103A CA2220103A1 CA 2220103 A1 CA2220103 A1 CA 2220103A1 CA 002220103 A CA002220103 A CA 002220103A CA 2220103 A CA2220103 A CA 2220103A CA 2220103 A1 CA2220103 A1 CA 2220103A1
Authority
CA
Canada
Prior art keywords
amoxycillin
composition
clavulanic acid
paediatric
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002220103A
Other languages
English (en)
Other versions
CA2220103C (fr
Inventor
Richard Peregrine Bax
Mike Gale Ramsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
GlaxoSmithKline LLC
Original Assignee
Smithkline Beecham P.L.C.
Richard Peregrine Bax
Mike Gale Ramsey
Smithkline Beecham Corporation
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by Smithkline Beecham P.L.C., Richard Peregrine Bax, Mike Gale Ramsey, Smithkline Beecham Corporation, Glaxosmithkline Llc filed Critical Smithkline Beecham P.L.C.
Priority claimed from PCT/EP1996/001881 external-priority patent/WO1996034605A1/fr
Publication of CA2220103A1 publication Critical patent/CA2220103A1/fr
Application granted granted Critical
Publication of CA2220103C publication Critical patent/CA2220103C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
CA002220103A 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique Expired - Lifetime CA2220103C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GB9508989.2 1995-05-03
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment
GB9523655.0 1995-11-18
PCT/EP1996/001881 WO1996034605A1 (fr) 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique

Publications (2)

Publication Number Publication Date
CA2220103A1 true CA2220103A1 (fr) 1996-11-07
CA2220103C CA2220103C (fr) 2006-06-20

Family

ID=37392932

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220103A Expired - Lifetime CA2220103C (fr) 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique

Country Status (1)

Country Link
CA (1) CA2220103C (fr)

Also Published As

Publication number Publication date
CA2220103C (fr) 2006-06-20

Similar Documents

Publication Publication Date Title
EP1013274A3 (fr) Composition comprenant amoxycillin et acide clavulanique
EP1093812A3 (fr) Composition pharmaceutique contenant de l'amoxicilline et du clavulanate
EP1243267A3 (fr) Composition pharmaceutique contenant de l'amoxicilline et du clavulanate
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
CA2185119A1 (fr) Forme galenique pour l'administration d'un medicament dans une formulation liquide
CA2215329A1 (fr) Emploi d'un anti-inflammatoire non steroidien r dans une composition protectrice pour le traitement du cancer colorectal
CA2366304A1 (fr) Nouveau procede de traitement
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
AU5863894A (en) Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AU2617692A (en) Novel acylals of imidazole-5-carboxylic acid derivatives, process for their preparation and their use
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
CA2231176A1 (fr) Composition pour administration rectale a action de longue duree
AU2230692A (en) Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof
AU1852597A (en) Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
EP0393707A3 (fr) Composés bio-actifs associés à des liposomes et leur utilisation dans des préparations pharmaceutiques
IE812572L (en) Pharmaceutical preparation
CA2220103A1 (fr) Compositions a base d'amoxycilline et d'acide clavulanique
MX9708383A (es) Composicion que comprende amoxicilina y acido clavulanico.
AU5739499A (en) Pharmaceutical formulation of sodium amoxycillin and potassium clavulanate
AU7315596A (en) Pharmaceutical composition for topical application
AU2776389A (en) Beta-lactam antibiotics, processes for their preparation and their use as and in medicaments
MX9605055A (es) Tableta revestida de polimero que comprende amoxicilina y clavulanato.
SI0825860T1 (en) Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients
CA2081348A1 (fr) Formulation veterinaire d'amoxycilline et d'acide clavunalique et leurs derives
Migueres et al. In vitro and in vivo activity of clavulanic acid-amoxycillin association in new extended broad-spectrum-betalactamase-producing Klebsiella pneumoniae.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160502